New-onset diabetes and antihypertensive therapy: comments on ALLHAT trial
The development of new-onset diabetes is frequent during the follow-up of treated hypertensive patients. The prevalence of such an event seems to differ depending on the type of antihypertensive therapy used to control blood pressure. Diuretics and -blockers and their association are particularly ha...
Main Authors: | Cristina Sierra, Luis M Ruilope |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2003-09-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.3317/jraas.2003.026 |
Similar Items
-
Comments on ALLHAT and doxazosin
by: Krakoff Lawrence R
Published: (2001-11-01) -
Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone
by: Leenen Frans HH, et al.
Published: (2002-11-01) -
ALLHAT: definitive answers or continuing uncertainty?
by: Peter Sever
Published: (2003-03-01) -
A new era in hypertension research: discussing the findings of ALLHAT
by: Furberg Curt D
Published: (2001-11-01) -
Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins
by: Hooper Philip L
Published: (2001-09-01)